Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Endocrinology · Autoimmune Hypoparathyroidism

Is Autoimmune Hypoparathyroidism Linked to APS-1 Syndrome?

At a Glance

Autoimmune hypoparathyroidism is often isolated, but it can be an early sign of APS-1, a rare inherited condition that affects several glands. Childhood onset or persistent yeast infections may prompt regular screening and AIRE genetic testing.

Yes, autoimmune hypoparathyroidism can be linked to other autoimmune diseases, but having it does not guarantee you will develop another condition. Many people experience autoimmune hypoparathyroidism as an isolated issue. However, it can sometimes be the first sign of a broader immune system disorder, most notably a rare genetic condition called Autoimmune Polyglandular Syndrome Type 1 (APS-1) [1][2].

Understanding these connections can help you and your doctor decide on the right screening and monitoring plan for you.

Understanding APS-1 (APECED)

APS-1 (also known as APECED) is a rare inherited condition in which the immune system mistakenly attacks multiple healthy tissues in the body [3]. It typically begins in childhood and is classically defined by the presence of at least two of the following three main features [4][2]:

  • Hypoparathyroidism: This is often the very first endocrine (hormonal) issue to appear [5].
  • Chronic Mucocutaneous Candidiasis: These are persistent, hard-to-treat yeast infections on the skin, nails, or inside the mouth (not just occasional thrush). This is very commonly the earliest sign of APS-1 [4].
  • Primary Adrenal Insufficiency (Addison’s disease): A condition where the adrenal glands do not produce enough of the essential hormones cortisol and aldosterone. This often develops later in the disease course [4][5].

Because these manifestations tend to develop slowly over time, the initial presentation may include only one of these issues [4]. If you were diagnosed with hypoparathyroidism in childhood or have a history of chronic yeast infections, your doctor will likely consider APS-1 [6]. Genetic testing for mutations in the AIRE gene can support the diagnosis even if other features haven’t appeared yet [1]. Because APS-1 is usually an autosomal recessive genetic condition, you can have it even if no one else in your family is affected [7].

Other Conditions Associated with APS-1

If you are diagnosed with APS-1, you may be at higher risk for other conditions. (If you have isolated autoimmune hypoparathyroidism, your risk for these specific issues is much lower.) These can include:

  • Autoimmune Thyroid Disease: The immune system attacks the thyroid, often leading to hypothyroidism (an underactive thyroid) [8].
  • Type 1 Diabetes: The immune system attacks the insulin-producing cells in the pancreas [5].
  • Skin and Hair Changes: These can include vitiligo (loss of skin pigment) or alopecia (hair loss) [6].
  • Digestive and Liver Issues: Some individuals develop autoimmune enteropathy or malabsorption (conditions causing chronic diarrhea and severe nutrient absorption problems) or autoimmune hepatitis (liver inflammation) [2][6].
  • Reproductive Challenges: These may involve premature ovarian insufficiency (loss of normal function of the ovaries before age 40) or reduced testicular function [6].

(Note: Enamel hypoplasia, or poorly formed, thin tooth enamel, can also occur in childhood. This is often a consequence of childhood hypocalcemia or a distinct feature of APS-1, rather than a separate autoimmune disease [8][5].)

How Should You Be Screened?

Screening depends heavily on whether APS-1 is suspected or confirmed, or if you are thought to have isolated autoimmune hypoparathyroidism.

  • Scheduled Surveillance for APS-1: If you have confirmed or suspected APS-1, your endocrinologist will likely recommend regular, ongoing monitoring for other conditions, even if you feel completely fine. New issues can develop gradually without obvious symptoms, making regular check-ups essential [9].
  • Symptom-Triggered Testing: If you have isolated autoimmune hypoparathyroidism, screening may be guided more by your specific symptoms and family history [10]. Keep in mind that symptoms like fatigue or bowel changes can have many causes and do not automatically mean you have another autoimmune disease.
  • Autoantibody Tests vs. Function Tests: Doctors may use blood tests to look for autoantibodies (such as 21-hydroxylase antibodies for the adrenal glands or specific thyroid antibodies). These proteins indicate your immune system is targeting an organ, which points to an increased risk—but a positive antibody test does not necessarily mean the organ has failed, and a negative test does not guarantee you won’t get the disease [11]. To check if an organ is actually working, doctors use function tests, such as measuring morning cortisol and ACTH (or performing a stimulation test) for adrenal function, or TSH and free T4 for the thyroid [5].

Warning Signs: When to Seek Urgent Care

Primary adrenal insufficiency (Addison’s disease) can become a life-threatening emergency known as an adrenal crisis. Do not wait for a routine appointment if you experience severe or rapidly worsening symptoms. Seek emergency medical care immediately if you develop [12]:

  • Fainting, extreme dizziness, or severe weakness
  • Confusion
  • Persistent vomiting or diarrhea, or an inability to keep fluids down
  • Severe abdominal pain

If you are already diagnosed with adrenal insufficiency and take replacement steroids, always follow your clinician’s sick-day or emergency plan.

Common questions in this guide

Does having autoimmune hypoparathyroidism mean I have APS-1?
No. Autoimmune hypoparathyroidism can occur by itself, and having it does not mean you will develop another autoimmune disease. APS-1 is more likely to be considered when hypoparathyroidism began in childhood, persistent mucocutaneous yeast infections or other gland problems are present, or testing identifies an AIRE gene mutation.
What is APS-1, also called APECED?
APS-1 is a rare inherited disorder in which the immune system attacks several healthy tissues. It classically involves at least two of hypoparathyroidism, chronic mucocutaneous candidiasis, and primary adrenal insufficiency, although one feature may appear first. AIRE gene testing can support the diagnosis.
Which autoimmune conditions can be associated with APS-1?
They can include autoimmune thyroid disease, type 1 diabetes, vitiligo or alopecia, autoimmune enteropathy or malabsorption, autoimmune hepatitis, and reduced ovarian or testicular function. These conditions are more concerning when APS-1 is present; the risk is much lower with isolated autoimmune hypoparathyroidism.
What tests check for autoimmune diseases linked to hypoparathyroidism?
Clinicians may use autoantibody tests to look for immune targeting of organs and function tests to see whether an organ is working. Examples include 21-hydroxylase antibodies and morning cortisol or ACTH for the adrenal glands, plus thyroid antibodies, TSH, and free T4. A positive antibody result can indicate increased risk but does not prove organ failure, and a negative result cannot guarantee the disease will not develop.
When should I seek emergency care for possible adrenal insufficiency?
Seek emergency care for fainting, severe dizziness or weakness, confusion, persistent vomiting or diarrhea, inability to keep fluids down, or severe abdominal pain. These can be signs of an adrenal crisis, which can be life-threatening. If you already take steroid replacement, follow your clinician's emergency or sick-day plan.
How often should someone with suspected APS-1 be screened?
People with confirmed or suspected APS-1 often need regular, ongoing monitoring because new problems can develop gradually without obvious symptoms. With isolated autoimmune hypoparathyroidism, testing is usually guided by symptoms, personal history, and family history. Your endocrinologist can set the schedule and choose the tests.

Get notified when new evidence is published on Hypoparathyroidism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

    Fierabracci A, Arena A, Toto F, et al.

    Journal of endocrinological investigation 2021; (44(4)):661-677 doi:10.1007/s40618-020-01376-5.

    PMID: 32767280
  2. 2

    A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.

    Bruserud Ø, Oftedal BE, Landegren N, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(8)):2975-83 doi:10.1210/jc.2016-1821.

    PMID: 27253668
  3. 3

    Rapid whole-genome sequencing identifies a novel AIRE variant associated with autoimmune polyendocrine syndrome type 1.

    Sanford E, Watkins K, Nahas S, et al.

    Cold Spring Harbor molecular case studies 2018; (4(3)) doi:10.1101/mcs.a002485.

    PMID: 29437776
  4. 4

    Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1.

    Lima Ferreira J, Simões de Carvalho F, Marques AP, Príncipe RM

    Endocrinology, diabetes & metabolism case reports 2020; (2020()).

    PMID: 33434148
  5. 5

    New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.

    Bugălă NM, Carsote M, Stoica LE, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(9)) doi:10.3390/diagnostics12092080.

    PMID: 36140482
  6. 6

    Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.

    Garelli S, Dalla Costa M, Sabbadin C, et al.

    Journal of endocrinological investigation 2021; (44(11)):2493-2510 doi:10.1007/s40618-021-01585-6.

    PMID: 34003463
  7. 7

    Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism.

    Cranston T, Boon H, Olesen MK, et al.

    European journal of endocrinology 2022; (187(1)):111-122 doi:10.1530/EJE-21-0730.

    PMID: 35521792
  8. 8

    Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway.

    Kucuka I, Wolff ASB, Breivik L, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(7)):1927-1939 doi:10.1210/clinem/dgag060.

    PMID: 41678364
  9. 9

    Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.

    Humbert L, Proust-Lemoine E, Dubucquoi S, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(3)):e757-e773 doi:10.1210/clinem/dgae211.

    PMID: 38605470
  10. 10

    Genetic Screening in a Large Chinese Cohort of Childhood Onset Hypoparathyroidism by Next-Generation Sequencing Combined with TBX1-MLPA.

    Wang Y, Nie M, Wang O, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(12)):2254-2263 doi:10.1002/jbmr.3854.

    PMID: 31433868
  11. 11

    Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes.

    Savvateeva EN, Yukina MY, Nuralieva NF, et al.

    International journal of molecular sciences 2021; (22(11)) doi:10.3390/ijms22115502.

    PMID: 34071130
  12. 12

    Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.

    Baioumi A, Darma K, Selvarajan L, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(4)):396-405 doi:10.1515/jpem-2025-0522.

    PMID: 41712317

This page is for informational purposes only and does not constitute medical advice. An endocrinologist or other qualified clinician should interpret your test results and advise you about screening and urgent symptoms.